Skip to main content

Market Overview


  • BBIO, BBP, Biotech, cancer, EIDX, genes

    BridgeBio Pharma IPO: What You Need To Know

    Wednesday, June 26, 2019 - 7:46am

    The week will see the listing of a late entrant into the arena, but it nonetheless has an impressive pipeline of investigational assets targeting genetic diseases. The IPO Terms BridgeBio Pharma (NASDAQ: BBIO),founded in 2015 and headquartered in Palo Alto, California, is set to offer 15 million...